Targeting the Achilles’ heel of cancer cells via integrin-mediated delivery of ROS-generating dihydrolipoamide dehydrogenase
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Achilles’ heel of cancer cells via integrin-mediated delivery of ROS-generating dihydrolipoamide dehydrogenase
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-14
DOI
10.1038/s41388-019-0775-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human dihydrolipoamide dehydrogenase (E3) deficiency: Novel insights into the structural basis and molecular pathomechanism
- (2018) Attila Ambrus et al. NEUROCHEMISTRY INTERNATIONAL
- RGD-modified dihydrolipoamide dehydrogenase conjugated to titanium dioxide nanoparticles – switchable integrin-targeted photodynamic treatment of melanoma cells
- (2018) Avraham Dayan et al. RSC Advances
- Reactive oxygen species and cancer paradox: To promote or to suppress?
- (2017) Sehamuddin Galadari et al. FREE RADICAL BIOLOGY AND MEDICINE
- ROS-modulated therapeutic approaches in cancer treatment
- (2017) Muhammad Hassan Raza et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The involvement of coordinative interactions in the binding of dihydrolipoamide dehydrogenase to titanium dioxide-Localization of a putative binding site
- (2017) Avraham Dayan et al. JOURNAL OF MOLECULAR RECOGNITION
- ROS Modulator Molecules with Therapeutic Potential in Cancers Treatments
- (2017) et al. MOLECULES
- Targeting Free Radicals in Oxidative Stress-Related Human Diseases
- (2017) Patrik Poprac et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
- (2017) Anish Babu et al. Scientific Reports
- A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
- (2017) Tobias G. Kapp et al. Scientific Reports
- The mitochondrial pyruvate carrier in health and disease: To carry or not to carry?
- (2016) Tom Bender et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Mitochondrial ROS regulation of proliferating cells
- (2016) Lauren Diebold et al. FREE RADICAL BIOLOGY AND MEDICINE
- Novel murine tumour models depend on strain and route of inoculation
- (2016) Qiang Fu et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- A Green Light-Triggerable RGD Peptide for Photocontrolled Targeted Drug Delivery: Synthesis and Photolysis Studies
- (2016) Albert Gandioso et al. JOURNAL OF ORGANIC CHEMISTRY
- Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo
- (2016) Wei Chen et al. Small
- Mitochondrial pyruvate import and its effects on homeostasis
- (2015) Benoît Vanderperre et al. CURRENT OPINION IN CELL BIOLOGY
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Strategies To Inhibit Tumor Associated Integrin Receptors: Rationale for Dual and Multi-Antagonists
- (2014) Helen M. Sheldrake et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment
- (2014) Yaping Yu et al. World Journal of Surgical Oncology
- Molecular dynamics study of the structural basis of dysfunction and the modulation of reactive oxygen species generation by pathogenic mutants of human dihydrolipoamide dehydrogenase
- (2013) Attila Ambrus et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy
- (2013) V. Nogueira et al. CLINICAL CANCER RESEARCH
- Optimized multimodal nanoplatforms for targeting αvβ3 integrins
- (2013) Julie Bolley et al. Nanoscale
- RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
- (2012) Fabienne Danhier et al. MOLECULAR PHARMACEUTICS
- Inhibitors of Succinate: Quinone Reductase/Complex II Regulate Production of Mitochondrial Reactive Oxygen Species and Protect Normal Cells from Ischemic Damage but Induce Specific Cancer Cell Death
- (2011) Stephen J. Ralph et al. PHARMACEUTICAL RESEARCH
- Cancer cell killing via ROS: To increase or decrease, that is the question
- (2010) Jie Wang et al. CANCER BIOLOGY & THERAPY
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- α-Ketoglutarate dehydrogenase contributes to production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ
- (2008) G. Zündorf et al. NEUROSCIENCE
- Endocytic transport of integrins during cell migration and invasion
- (2008) Patrick Caswell et al. TRENDS IN CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More